Strait of Hormuz Closure Threatens U.S. Generic Drug Supply and Beyond

Escalating tensions in the Middle East, specifically surrounding the Strait of Hormuz, pose a significant threat to the supply of generic drugs in the United States, with ripple effects extending to various industries. The potential closure of this vital shipping lane could disrupt the flow of key materials needed for pharmaceutical manufacturing, leading to shortages and increased costs for consumers.

The Critical Role of the Strait of Hormuz

The Strait of Hormuz, a narrow waterway between Iran and Oman, is a crucial chokepoint for global oil and gas shipments. However, its importance extends far beyond energy. Approximately 40% of the world’s oil and a significant portion of liquefied natural gas transit through this strait daily. More critically for the U.S. Pharmaceutical sector, nearly half of all generic prescriptions filled in the U.S. Originate in India ¹. India relies heavily on the Strait of Hormuz for the import of essential materials used in drug production, including petroleum-based chemicals, and for exporting finished medications to the U.S.

Impact on Generic Drug Production

Generic drug manufacturing relies on a complex supply chain. While India is a major producer of active pharmaceutical ingredients (APIs), it is increasingly dependent on China for the key starting materials needed to create those APIs ². China, in turn, relies on the Strait of Hormuz for the delivery of crude oil and natural gas, which are then processed into the necessary petrochemicals. Disruptions to the flow of these materials could severely hamper India’s ability to produce and export generic drugs to the U.S.

Currently, most U.S. Medical distributors maintain a 30- to 60-day supply of medications to buffer against disruptions ¹. However, a prolonged closure of the Strait of Hormuz could quickly deplete these stockpiles, leading to shortages of critical medications, including those for common conditions like diabetes, hypertension, and infections.

Beyond Pharmaceuticals: Broader Economic Consequences

The potential closure of the Strait of Hormuz extends far beyond the pharmaceutical industry. It threatens supply chains across numerous sectors, including metals, manufacturing, farming, and food production ¹. The economic consequences would include higher oil prices, increased costs for raw materials, and potential delays in the delivery of goods.

Oil is not solely used for fuel; it’s a fundamental feedstock for a vast array of products, including plastics, fertilizers, and pharmaceuticals ⁴. These feedstocks are essential for manufacturing medical tubing, sterile packaging, and disposable medical supplies, further exacerbating the potential impact on the healthcare system.

International Response and Mitigation Efforts

U.S. President Donald Trump is actively seeking assistance from international allies, including NATO members and China, to ensure the protection of ships navigating the Strait of Hormuz ¹. However, the situation remains volatile, and the risks associated with higher oil prices, drug shortages, and supply chain disruptions are increasing daily.

Looking Ahead

The situation in the Strait of Hormuz demands close monitoring. While existing stockpiles may provide a temporary buffer, a prolonged disruption could have significant consequences for the U.S. Healthcare system and the broader economy. The vulnerability of the U.S. Pharmaceutical supply chain highlights the need for diversification of sourcing and increased domestic production of essential medications and raw materials.